These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 15466268

  • 1. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.
    Dai C, Yang J, Bastacky S, Xia J, Li Y, Liu Y.
    J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268
    [Abstract] [Full Text] [Related]

  • 2. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J, Dai C, Liu Y.
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [Abstract] [Full Text] [Related]

  • 3. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S, Nakamura T.
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [Abstract] [Full Text] [Related]

  • 4. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
    Yang J, Liu Y.
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
    Mou S, Wang Q, Shi B, Gu L, Ni Z.
    Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats.
    Yuan F, Liu YH, Liu FY, Peng YM, Tian JW.
    Mol Med Rep; 2014 Jun; 9(6):2293-300. PubMed ID: 24718692
    [Abstract] [Full Text] [Related]

  • 7. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwara T, Fujiwara H.
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [Abstract] [Full Text] [Related]

  • 8. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S, Nyengaard JR, Wogensen L.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [Abstract] [Full Text] [Related]

  • 10. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
    Hirano S, Bless D, Heisey D, Ford C.
    Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
    [Abstract] [Full Text] [Related]

  • 11. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
    Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M.
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
    [Abstract] [Full Text] [Related]

  • 12. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 13. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M, Taniguchi H, Koya D, Kanasaki K, Sho R, Kato Y, Kojima R, Haneda M, Inomata N.
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [Abstract] [Full Text] [Related]

  • 14. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN, LaPage J, Hirschberg R.
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH, Yokozeki H, Takagawa S, Yamamoto T, Satoh T, Kaneda Y, Katayama I, Nishioka K.
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [Abstract] [Full Text] [Related]

  • 16. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.
    Dai C, Liu Y.
    J Am Soc Nephrol; 2004 Jun; 15(6):1402-12. PubMed ID: 15153551
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes.
    Bu X, Zhou Y, Zhang H, Qiu W, Chen L, Cao H, Fang L, Wen P, Tan R, Yang J.
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F784-92. PubMed ID: 21775482
    [Abstract] [Full Text] [Related]

  • 20. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
    Long X, Xiong SD, Xiong WN, Xu YJ.
    Chin Med J (Engl); 2007 Aug 20; 120(16):1432-7. PubMed ID: 17825173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.